Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,285 | 4,284 | 3,900 | 2,206 | 4,040 |
| Depreciation Amortization | 7,743 | 683 | 562 | 564 | 471 |
| Accounts receivable | -9,551 | -472 | 241 | -1,007 | N/A |
| Accounts payable and accrued liabilities | 55 | N/A | -1 | -1,369 | -511 |
| Other Working Capital | -15,433 | -1,355 | -19 | -4,600 | -151 |
| Other Operating Activity | 10,529 | 975 | -240 | 4,624 | 521 |
| Operating Cash Flow | $-1,372 | $4,115 | $4,443 | $419 | $4,370 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | -4 | -300 | -314 | -172 |
| Purchase Sale Intangibles | -2,018 | -2,444 | -3,393 | -392 | -5,516 |
| Other Investing Activity | -2,335 | -2,444 | -3,393 | -392 | -5,516 |
| Investing Cash Flow | $-2,363 | $-2,448 | $-3,693 | $-706 | $-5,688 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,217 | N/A | N/A | N/A | N/A |
| Debt Issued | -35 | N/A | N/A | N/A | N/A |
| Debt Repayment | 35 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 749 | -2,331 | 0 | -63 | 88 |
| Financing Cash Flow | $3,966 | $-2,331 | $0 | $-63 | $88 |
| Exchange Rate Effect | -37 | -9 | 23 | 5 | 111 |
| Beginning Cash Position | 488 | 1,160 | 387 | 732 | 1,851 |
| End Cash Position | 682 | 488 | 1,160 | 387 | 732 |
| Net Cash Flow | $194 | $-672 | $773 | $-346 | $-1,118 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,372 | 4,115 | 4,443 | 419 | 4,370 |
| Capital Expenditure | -32 | -9 | -300 | -314 | -192 |
| Free Cash Flow | -1,404 | 4,107 | 4,143 | 105 | 4,179 |